Αρχική World News A Subgroup of Patients with a Very Poor Prognosis Diffuse Intrinsic Pontine... World News A Subgroup of Patients with a Very Poor Prognosis Diffuse Intrinsic Pontine Glioma Linked to TP53 Alterations Από Ogkologos - 12 Μαΐου, 2026 324 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the BIOMEDE study Source ΠΑΡΟΜΟΙΑ ΑΡΘΡΑΠΕΡΙΣΣΟΤΕΡΑ ΑΠΟ ΤΟΝ ΔΗΜΙΟΥΡΓΟ Ahead of the Special European Council Meeting on 26-27 November, ESMO Calls on EU Governments to Continue Support for the Cancer Mission European Parliament backs key priorities advocated by ESMO for cancer research and innovation FDA approves giredestrant in combination with everolimus for ER-positive, HER2-negative, ESR1-mutated locally advanced or metastatic breast cancer MOST POPULAR Trastuzumab Emtansine Improves OS with Sustained Improvement in iDFS Among Patients... 22 Ιανουαρίου, 2025 105-Year-Old Woman Sets Record For 100-Meter Dash 16 Νοεμβρίου, 2021 Meeting Cancer Survivors’ Psychosocial Health Needs: A Conversation with Dr. Patricia... 7 Ιουνίου, 2022 “After a fire and a pandemic, it felt amazing to finish... 1 Νοεμβρίου, 2021 Φόρτωση περισσοτέρων HOT NEWS What to Know About Exercising During Prostate Cancer: An Expert Q&A Blind Man Overcomes Life Of Struggles & Becomes An Incredible Woodworker EMA Recommends Granting a Marketing Authorisation for Generic Abiraterone for the... How Pelvic Floor Therapy Can Help People With Prostate Cancer and...